Keith C Kummerfeld - Net Worth and Insider Trading

Keith C Kummerfeld Net Worth

The estimated net worth of Keith C Kummerfeld is at least $38,271 dollars as of 2024-06-03. Keith C Kummerfeld is the See Remarks of Arcturus Therapeutics Holdings Inc and owns about 950 shares of Arcturus Therapeutics Holdings Inc (ARCT) stock worth over $38,271. Details can be seen in Keith C Kummerfeld's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Keith C Kummerfeld has not made any transactions after 2023-07-14 and currently still holds the listed stock(s).

Transaction Summary of Keith C Kummerfeld

To

Keith C Kummerfeld Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Keith C Kummerfeld owns 1 companies in total, including Arcturus Therapeutics Holdings Inc (ARCT) .

Click here to see the complete history of Keith C Kummerfeld’s form 4 insider trades.

Insider Ownership Summary of Keith C Kummerfeld

Ticker Comapny Transaction Date Type of Owner
ARCT Arcturus Therapeutics Holdings Inc 2023-07-14 See Remarks

Keith C Kummerfeld Latest Holdings Summary

Keith C Kummerfeld currently owns a total of 1 stock. Keith C Kummerfeld owns 950 shares of Arcturus Therapeutics Holdings Inc (ARCT) as of July 14, 2023, with a value of $38,271.

Latest Holdings of Keith C Kummerfeld

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARCT Arcturus Therapeutics Holdings Inc 2023-07-14 950 40.29 38,271

Holding Weightings of Keith C Kummerfeld


Keith C Kummerfeld Form 4 Trading Tracker

According to the SEC Form 4 filings, Keith C Kummerfeld has made a total of 4 transactions in Arcturus Therapeutics Holdings Inc (ARCT) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Arcturus Therapeutics Holdings Inc is the sale of 6,968 shares on July 14, 2023, which brought Keith C Kummerfeld around $243,880.

Insider Trading History of Keith C Kummerfeld

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Keith C Kummerfeld Trading Performance

GuruFocus tracks the stock performance after each of Keith C Kummerfeld's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Keith C Kummerfeld is 9.19%. GuruFocus also compares Keith C Kummerfeld's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith C Kummerfeld within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Keith C Kummerfeld's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Keith C Kummerfeld

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 21.79 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 20.08 LIMIT LIMIT LIMIT LIMIT LIMIT

Keith C Kummerfeld Ownership Network

Ownership Network List of Keith C Kummerfeld

No Data

Ownership Network Relation of Keith C Kummerfeld

Insider Network Chart

Keith C Kummerfeld Owned Company Details

What does Arcturus Therapeutics Holdings Inc do?

Who are the key executives at Arcturus Therapeutics Holdings Inc?

Keith C Kummerfeld is the See Remarks of Arcturus Therapeutics Holdings Inc. Other key executives at Arcturus Therapeutics Holdings Inc include Chief Scientific Officer & COO Pad Chivukula , director & 10 percent owner & President and CEO Joseph E Payne , and director & 10 percent owner Ultragenyx Pharmaceutical Inc. .

Arcturus Therapeutics Holdings Inc (ARCT) Insider Trades Summary

Over the past 18 months, Keith C Kummerfeld made 2 insider transaction in Arcturus Therapeutics Holdings Inc (ARCT) with a net sale of 13,936. Other recent insider transactions involving Arcturus Therapeutics Holdings Inc (ARCT) include a net sale of 116,000 shares made by Pad Chivukula , a net purchase of 2,222 shares made by Magda Marquet ,

In summary, during the past 3 months, insiders sold 26,000 shares of Arcturus Therapeutics Holdings Inc (ARCT) in total and bought 0 shares, with a net sale of 26,000 shares. During the past 18 months, 129,936 shares of Arcturus Therapeutics Holdings Inc (ARCT) were sold and 2,222 shares were bought by its insiders, resulting in a net sale of 127,714 shares.

Arcturus Therapeutics Holdings Inc (ARCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcturus Therapeutics Holdings Inc Insider Transactions

No Available Data

Keith C Kummerfeld Mailing Address

Above is the net worth, insider trading, and ownership report for Keith C Kummerfeld. You might contact Keith C Kummerfeld via mailing address: 10628 Science Center Drive, Suite 250, San Diego Ca 92121.

Discussions on Keith C Kummerfeld

No discussions yet.